Gynecological Malignancies in Elderly Patients: Is Age 70 a Limit to Standard-Dose Chemotherapy? An Italian Retrospective Toxicity Multicentric Study

Author： Ceccaroni M.   D'Agostino G.   Ferrandina G.   Gadducci A.   Di Vagno G.   Pignata S.   Poerio A.   Salerno M.G.   Fanucchi A.   Lapresa M.T.   Tambaro R.   Scambia G.  

Publisher： Academic Press

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.85, Iss.3, 2002-06, pp. : 445-450

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should Adjuvant Chemotherapy be used to Treat Breast Cancer in Elderly Patients (>= 70 years of age)?

By Monfardini S.   Perrone F.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1723-1724

Elsevier

Access to resources Recommend Favorite

Should Adjuvant Chemotherapy be used to Treat Breast Cancer in Elderly Patients(>= 70 years of age)?

By Fentiman I.   Monfardini S.   Perrone F.   Balducci L.   Extermann M.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1720-1722

Elsevier

Access to resources Recommend Favorite

Should Adjuvant Chemotherapy be used to Treat Breast Cancer in Elderly Patients (>= 70 years of age)?

By Fentiman I.S.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1722-1723

Elsevier

Access to resources Recommend Favorite

High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: First results of a randomized trial

By Verrill Mark  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 41-43

Informa Healthcare

Access to resources Recommend Favorite

A retrospective study of unicentric and multicentric Castleman's disease: a report of 52 patients

By Ye Bo  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1171-1178

Humana Press, Inc

Access to resources Recommend Favorite